Morgana/CHP-1 is a ubiquitously expressed protein able to inhibit ROCK II kinase activity. We have previously demonstrated that morgana haploinsufficiency leads to multiple centrosomes, genomic instability and higher susceptibility to tumour development. While a large fraction of human cancers has shown morgana down-regulation, a small subset of tumours were shown to express high morgana levels. Here we demonstrate that high morgana expression in different breast cancer subtypes correlates with high tumour grade, mitosis number and lymph node positivity. Moreover, morgana overexpression induces transformation in NIH-3T3 cells and strongly protects them from various apoptotic stimuli. From a mechanistic point of view, we demonstrate that morgana causes PTEN destabilisation, by inhibiting ROCK activity, hence triggering the PI3K/AKT survival pathway. In turn, morgana down-regulation in breast cancer cells that express high morgana levels increases PTEN expression and leads to sensitisation of cells to chemotherapy.

Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathway.

FUSELLA, FEDERICA;FERRETTI, Roberta;RECUPERO, DANIELE;DI SAVINO, AUGUSTA;TORNILLO, GIUSY;SILENGO, Lorenzo;TURCO, Emilia;CABODI, Sara;PROVERO, Paolo;PANDOLFI DE RINALDIS, Pier Paolo;SAPINO, Anna;TARONE, Guido;BRANCACCIO, Mara
Last
2014

Abstract

Morgana/CHP-1 is a ubiquitously expressed protein able to inhibit ROCK II kinase activity. We have previously demonstrated that morgana haploinsufficiency leads to multiple centrosomes, genomic instability and higher susceptibility to tumour development. While a large fraction of human cancers has shown morgana down-regulation, a small subset of tumours were shown to express high morgana levels. Here we demonstrate that high morgana expression in different breast cancer subtypes correlates with high tumour grade, mitosis number and lymph node positivity. Moreover, morgana overexpression induces transformation in NIH-3T3 cells and strongly protects them from various apoptotic stimuli. From a mechanistic point of view, we demonstrate that morgana causes PTEN destabilisation, by inhibiting ROCK activity, hence triggering the PI3K/AKT survival pathway. In turn, morgana down-regulation in breast cancer cells that express high morgana levels increases PTEN expression and leads to sensitisation of cells to chemotherapy.
234
2
152
163
http://onlinelibrary.wiley.com/doi/10.1002/path.4341/abstract
PTEN, ROCK, breast cancer, chemoresistance, morgana
Fusella F; Ferretti R; Recupero D; Rocca S; Di Savino A; Tornillo G; Silengo L; Turco E; Cabodi S; Provero P; Pandolfi PP; Sapino A; Tarone G; Brancaccio M.
File in questo prodotto:
File Dimensione Formato  
Fusella et al., J Pathol, 2014.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 2.03 MB
Formato Adobe PDF
2.03 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/148219
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 19
social impact